Poseida Therapeutics, Inc.
PSTXDelisted Jan 8, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001661460
Poseida Therapeutics, Inc. was delisted on Jan 8, 2025; its insiders filed their last Form 4 on Jan 10, 2025; 116 institutions reported holding it in 13F filings for Q4 2024, worth $519.2M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Poseida Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 65 | 2 | 66 | +3 |
| Shares | 26.2M | 29.8K | 26.2M | +80.0K (+0.3%) |
| Value | $190.7M | $217.0K | $178.4M | −$12.1M (−6.3%) |
2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Poseida Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Natixis | 1,700,000 | $11.6M | 0.04% |
| Silverarc Capital Management, LLC | 234,932 | $1.60M | 0.72% |
| Dimensional Fund Advisors LP | 97,334 | $663.0K | 0.00% |
| Gsa Capital Partners LLP | 84,701 | $577.0K | 0.07% |
| Blair William & Co | 48,963 | $333.0K | 0.00% |
| Cantor Fitzgerald, L. P. | 25,205 | $172.0K | 0.01% |
| Citadel Advisors LLC | 25,014 | $170.0K | 0.00% |
| Atom Investors LP | 24,933 | $170.0K | 0.05% |
| Cubist Systematic Strategies, LLC | 23,432 | $160.0K | 0.00% |
| Knott David M Jr | 19,566 | $133.0K | 0.05% |
| Susquehanna International Group, LLP | 16,863 | $115.0K | 0.00% |
| Parametric Portfolio Associates LLC | 13,113 | $89.0K | 0.00% |
| UBS Group AG | 9,795 | $67.0K | 0.00% |
| TD Waterhouse Canada Inc. | 1,500 | $10.3K | 0.00% |
| Edge Wealth Management LLC | 50 | $1.00K | 0.00% |
| Parallel Advisors, LLC | 105 | $1.00K | 0.00% |
| Lindbrook Capital, LLC | 101 | $1.00K | 0.00% |
| High Net Worth Advisory Group LLC | 200 | $1.00K | 0.00% |
| Toronto Dominion Bank | 3 | $0 | 0.00% |
| Point72 Hong Kong Ltd | 29 | $0 | 0.00% |
Sold out (17)
Institutions that held Poseida Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Perceptive Advisors LLC | 787,745 | $5.74M |
| Adage Capital Partners GP, L.L.C. | 755,969 | $5.51M |
| J. Goldman & Co LP | 301,391 | $2.20M |
| Schonfeld Strategic Advisors LLC | 289,179 | $2.11M |
| MCF Advisors LLC | 66,185 | $482.0K |
| Altium Capital Management LP | 32,238 | $235.0K |
| Virtus ETF Advisers LLC | 23,082 | $168.0K |
| SG Americas Securities, LLC | 21,323 | $155.0K |
| DekaBank Deutsche Girozentrale | 22,000 | $154.0K |
| State of Wisconsin Investment Board | 18,800 | $137.0K |
| Trexquant Investment LP | 12,442 | $91.0K |
| Invesco Ltd. | 11,629 | $85.0K |
| Penserra Capital Management LLC | 1,425 | $10.0K |
| Nisa Investment Advisors, LLC | 600 | $4.00K |
| Signaturefd, LLC | 98 | $1.00K |
| Simplex Trading, LLC | 181 | $1.00K |
| Allworth Financial LP | 100 | $1.00K |
Not filed for Q4 2021 yet (2)
Institutions that held Poseida Therapeutics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Knott David M | 29,566 | $216.0K |
| Berman Capital Advisors, LLC | 273 | $1.00K |